2 completed. 1 Phase 1, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Completed 1 |
| Phase 3 | 1 | Completed 1 |
Follow Helicobacter Pylori Infected Subjects: new trials by email Literature Review of Helicobacter Pylori Infected Subjects trials Research Report on Helicobacter Pylori Infected Subjects
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Study to Evaluate the Efficacy and Safety of DWP14012-based Triple Therapy in Eradication of Helicobacter Pylori DWP14012 40mg, DWC202301 30mg, Amoxicillin 1000mg - Helicobacter Pylori Infection, Helicobacter Pylori Infected Patients | Phase 3 | Completed | Daewoong Pharmaceutical Co. LTD. | 461 | 2024-02-06 | 2025-12-08 |
| Phase 1a/b Study on Safety of IMX101 in H. Pylori-negative and H. Pylori-infected Healthy Volunteers CTA control, IMX101 vaccine - Helicobacter Pylori Infected Subjects, Helicobacter Pylori Naive Subjects | Phase 1 | Completed | ImevaX | 72 | 2017-01-30 | 2019-02-15 |
Amoxicillin (1) · Clarithromycin (1) · fexuprazan (1)
Daewoong Pharmaceutical Co. LTD. (1) · ImevaX (1)
Germany (1) · South Korea (1)
Sandra Zivotic (1)
2015 (1)